Jess Lonner
Cancer survivorship has remarkably improved over the past decades; all the same, cancer survivors are burdened with multiple health complications primarily caused by their cancer medical care. Therapy-induced senescence is recognized as a basic mechanism contributory to adverse health complications in cancer survivors. during this mini-review, we'll discuss the recent literature describing the mechanisms of cancer therapy-induced senescence. We’ll target epithelial tissue cell senescence since it's been shown to be a key player in various vessel complications. We’ll additionally discuss novel senotherapeutic approaches that have the potential to combat therapy-induced epithelial tissue cell senescence.
English 
Spanish 
Chinese 
Russian 
German 
French 
Portuguese 
Hindi